Methods of treating mammals with eustachian tube dysfunctions

Abstract

The invention relates to methods of medically treating mammals with Eustachian tube dysfunctions, such as Meniere's disease, vertigo, Otitis Media (including Otitis Media with Effusion (OME), Acute Otitis Media (AOM) and Aerotitis Media (AM)) as well as other disorders which are characterized by ET dysfunction.

Description

technical field [0001] The present invention relates generally to medical methods of treating mammals, including humans, and in particular to methods of treating mammals suffering from Eustachian tube dysfunction. The invention also relates to the production of a medicament for the treatment of Eustachian tube dysfunction. Background technique [0002] The Eustachian tube ("ET"), also often referred to as the "Eustachian tube", connects the middle ear cavity to the back of the nose / pharynx (nasopharynx). The ET is a conduit of which one-third is made of bone and the rest is cartilage. In humans, the ET is generally closed by its collapsed walls, but it can open to let some air through to equalize the pressure between the middle ear and the external environment. Opening in this manner can be accomplished by swallowing, yawning, or chewing. Occlusion due to inability to self-regulate or achieve pressure equilibrium (eg, during aircraft flight, underwater diving, or due to c...

AI Technical Summary

Problems solved by technology

Decongestants and antihistamines are thought to reduce swelling of the mucous membranes, but there is no scientific evidence that decongestants or antihistamines help Eustachian tube function

Steroids have their potential drawbacks associated with serious side effects

Images